Ruprecht-Karls-Universität Heidelberg

Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML (2021) Jaramillo S, Krisam J, Le Cornet L, Kratzmann M, Baumann L, Sauer T, Crysandt M, et al. Journal article Comparative analysis of machine learning algorithms for computer-assisted reporting based on fully automated cross-lingual RadLex mappings (2021) Maros ME, Cho CG, Junge AG, Kaempgen B, Saase V, Siegel F, Trinkmann F, et al. Journal article Exposure to 16 h of normobaric hypoxia induces ionic edema in the healthy brain (2021) Biller A, Badde S, Heckel A, Guericke P, Bendszus M, Nagel AM, Heiland S, et al. Journal article Analysis of remaining motion using one innovative upper airway opening cervical collar and two traditional cervical collars (2021) Jung MK, von Ehrlich-Treuenstätt GV, Keil H, Grützner PA, Schneider NR, Kreinest M Journal article Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer (BMC Cancer, (2021), 21, 1, (920), 10.1186/s12885-021-08656-0) (2021) Stuerken C, Moebus V, Milde-Langosch K, Schmatloch S, Fasching P, Rueschoff J, Stickeler E, et al. Journal article, Erratum Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics (2021) Stojanović SD, Fuchs M, Liang C, Schmidt K, Xiao K, Just A, Pfanne A, et al. Journal article Human AZFb deletions cause distinct testicular pathologies depending on their extensions in Yq11 and the Y haplogroup: new cases and review of literature (2021) Vogt PH, Bender U, Deibel B, Kiesewetter F, Zimmer J, Strowitzki T Journal article, Review article Prediction of Complete Remission and Survival in Acute Myeloid Leukemia Using Supervised Machine Learning (2021) Eckardt JN, Rollig C, Kramer M, Stasik S, Georgi JA, Heisig P, Kroschinsky FP, et al. Conference contribution Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute BLymphoblastic Leukemia (INITIAL-1 trial) (2021) Stelljes M, Alakel N, Waesch R, Scholl S, Nachtkamp K, Rank A, Haenel M, et al. Conference contribution Evaluation of external stabilization of type II odontoid fractures in geriatric patients—An experimental study on a newly developed cadaveric trauma model (2021) Jung MK, von Ehrlich-Treuenstätt GV, Jung AL, Keil H, Grützner PA, Schneider NR, Kreinest M Journal article